Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group (Q73690532)
Jump to navigation
Jump to search
scientific article published on 01 September 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group |
scientific article published on 01 September 1997 |
Statements
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group (English)
M J Byrne
V Gebski
J Forbes
M H Tattersall
R J Simes
A S Coates
J Dewar
M Lunn
C Flower
P G Gill
1 September 1997